Dose-related alterations in metabolism of levodopa: possible mechanism for hypotensive effect.
D000959:Antihypertensive Agents / Q000494:pharmacology*; D001794:Blood Pressure; D002849:Chromatography, Gas; D004295:Dihydroxyphenylalanine / Q000378:metabolism* / Q000494:pharmacology / Q000627:therapeutic use / Q000652:urine; D004298:Dopamine / Q000652:urine; D004305:Dose-Response Relationship, Drug; D004837:Epinephrine / Q000652:urine; D006719:Homovanillic Acid / Q000652:urine; D006801:Humans; D008333:Mandelic Acids / Q000652:urine; D009638:Norepinephrine / Q000652:urine; D010300:Parkinson Disease / Q000188:drug therapy; D010648:Phenylacetates / Q000652:urine
D000959:Antihypertensive Agents; D008333:Mandelic Acids; D010648:Phenylacetates; D004295:Dihydroxyphenylalanine; D004298:Dopamine; D009638:Norepinephrine; D006719:Homovanillic Acid; D004837:Epinephrine